| Year |
Citation |
Score |
| 2020 |
Marks MJ, Loetz E, Ortiz NC, Herder PA, Collins AC. Partial and full deletion of nicotinic acetylcholine receptor α4 and β2 subunits reduces sensitivity to acute nicotine administration and development of tolerance following chronic nicotine administration. Behavioural Pharmacology. PMID 32568759 DOI: 10.1097/FBP.0000000000000575 |
0.459 |
|
| 2014 |
McClure-Begley TD, Grady SR, Marks MJ, Collins AC, Stitzel JA. Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes. Biochemical Pharmacology. 91: 87-96. PMID 24953818 DOI: 10.1016/J.Bcp.2014.06.010 |
0.754 |
|
| 2012 |
Collins AC, Pogun S, Nesil T, Kanit L. Oral Nicotine Self-Administration in Rodents. Journal of Addiction Research & Therapy. PMID 23264883 DOI: 10.4172/2155-6105.S2-004 |
0.417 |
|
| 2012 |
Zambrano CA, Salamander RM, Collins AC, Grady SR, Marks MJ. Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures. The Journal of Pharmacology and Experimental Therapeutics. 342: 245-54. PMID 22532626 DOI: 10.1124/jpet.112.192542 |
0.497 |
|
| 2012 |
McClure-Begley TD, Wageman CR, Grady SR, Marks MJ, McIntosh JM, Collins AC, Whiteaker P. A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus. Journal of Neurochemistry. 122: 48-57. PMID 22506481 DOI: 10.1111/J.1471-4159.2012.07759.X |
0.787 |
|
| 2011 |
Nesil T, Kanit L, Collins AC, Pogun S. Individual differences in oral nicotine intake in rats. Neuropharmacology. 61: 189-201. PMID 21504750 DOI: 10.1016/j.neuropharm.2011.03.027 |
0.426 |
|
| 2011 |
Marks MJ, McClure-Begley TD, Whiteaker P, Salminen O, Brown RW, Cooper J, Collins AC, Lindstrom JM. Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 337: 187-200. PMID 21228066 DOI: 10.1124/Jpet.110.178236 |
0.799 |
|
| 2010 |
Marks MJ, Meinerz NM, Brown RW, Collins AC. 86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization. Biochemical Pharmacology. 80: 1238-51. PMID 20599770 DOI: 10.1016/j.bcp.2010.06.040 |
0.55 |
|
| 2010 |
Grady SR, Salminen O, McIntosh JM, Marks MJ, Collins AC. Mouse striatal dopamine nerve terminals express alpha4alpha5beta2 and two stoichiometric forms of alpha4beta2*-nicotinic acetylcholine receptors. Journal of Molecular Neuroscience : Mn. 40: 91-5. PMID 19693710 DOI: 10.1007/s12031-009-9263-y |
0.461 |
|
| 2010 |
Marks MJ, Laverty DS, Whiteaker P, Salminen O, Grady SR, McIntosh JM, Collins AC. John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes. Journal of Molecular Neuroscience : Mn. 40: 96-104. PMID 19672723 DOI: 10.1007/S12031-009-9264-X |
0.489 |
|
| 2010 |
Stevens KE, Adams CE, Yonchek J, Zheng L, Collins AC. C3H ALPHA7 NICOTINIC RECEPTOR HETEROZYGOTE MICE AS A NEW MODEL OF SCHIZOPHRENIA Schizophrenia Research. 117: 510. DOI: 10.1016/j.schres.2010.02.975 |
0.422 |
|
| 2009 |
Whiteaker P, Wilking JA, Brown RW, Brennan RJ, Collins AC, Lindstrom JM, Boulter J. Pharmacological and immunochemical characterization of alpha2* nicotinic acetylcholine receptors (nAChRs) in mouse brain. Acta Pharmacologica Sinica. 30: 795-804. PMID 19498420 DOI: 10.1038/Aps.2009.68 |
0.452 |
|
| 2009 |
Collins AC, Salminen O, Marks MJ, Whiteaker P, Grady SR. The road to discovery of neuronal nicotinic cholinergic receptor subtypes. Handbook of Experimental Pharmacology. 85-112. PMID 19184647 DOI: 10.1007/978-3-540-69248-5_4 |
0.491 |
|
| 2009 |
McClure-Begley TD, King NM, Collins AC, Stitzel JA, Wehner JM, Butt CM. Acetylcholine-stimulated [3H]GABA release from mouse brain synaptosomes is modulated by alpha4beta2 and alpha4alpha5beta2 nicotinic receptor subtypes. Molecular Pharmacology. 75: 918-26. PMID 19139153 DOI: 10.1124/Mol.108.052274 |
0.788 |
|
| 2008 |
Gotti C, Moretti M, Meinerz NM, Clementi F, Gaimarri A, Collins AC, Marks MJ. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits. Molecular Pharmacology. 73: 1796-807. PMID 18337473 DOI: 10.1124/mol.108.045203 |
0.461 |
|
| 2008 |
Whiteaker P, Marks MJ, Christensen S, Dowell C, Collins AC, McIntosh JM. Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics. 325: 910-9. PMID 18323456 DOI: 10.1124/Jpet.108.136895 |
0.441 |
|
| 2008 |
Adams CE, Yonchek JC, Zheng L, Collins AC, Stevens KE. Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. Brain Research. 1194: 138-45. PMID 18199426 DOI: 10.1016/j.brainres.2007.12.007 |
0.458 |
|
| 2008 |
Schlaepfer IR, Hoft NR, Collins AC, Corley RP, Hewitt JK, Hopfer CJ, Lessem JM, McQueen MB, Rhee SH, Ehringer MA. The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biological Psychiatry. 63: 1039-46. PMID 18163978 DOI: 10.1016/J.Biopsych.2007.10.024 |
0.319 |
|
| 2008 |
Zeiger JS, Haberstick BC, Schlaepfer I, Collins AC, Corley RP, Crowley TJ, Hewitt JK, Hopfer CJ, Lessem J, McQueen MB, Rhee SH, Ehringer MA. The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Human Molecular Genetics. 17: 724-34. PMID 18055561 DOI: 10.1093/Hmg/Ddm344 |
0.398 |
|
| 2007 |
Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochemical Pharmacology. 74: 1235-46. PMID 17825262 DOI: 10.1016/J.Bcp.2007.07.032 |
0.542 |
|
| 2007 |
Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, Huang Q, McClure-Begley T, Lindstrom JM, Labarca C, Collins AC, Marks MJ, Lester HA. Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8202-18. PMID 17670967 DOI: 10.1523/Jneurosci.2199-07.2007 |
0.803 |
|
| 2007 |
Marks MJ, Meinerz NM, Drago J, Collins AC. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine. Neuropharmacology. 53: 390-405. PMID 17631923 DOI: 10.1016/j.neuropharm.2007.05.021 |
0.475 |
|
| 2007 |
Brown RW, Collins AC, Lindstrom JM, Whiteaker P. Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. Journal of Neurochemistry. 103: 204-15. PMID 17573823 DOI: 10.1111/J.1471-4159.2007.04700.X |
0.55 |
|
| 2007 |
Booker TK, Butt CM, Wehner JM, Heinemann SF, Collins AC. Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice. Pharmacology, Biochemistry, and Behavior. 87: 146-57. PMID 17509676 DOI: 10.1016/J.Pbb.2007.04.011 |
0.461 |
|
| 2007 |
Damaj MI, Fonck C, Marks MJ, Deshpande P, Labarca C, Lester HA, Collins AC, Martin BR. Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 321: 1161-9. PMID 17371806 DOI: 10.1124/jpet.106.112649 |
0.571 |
|
| 2007 |
Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR. Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Molecular Pharmacology. 71: 1563-71. PMID 17341654 DOI: 10.1124/mol.106.031492 |
0.525 |
|
| 2007 |
Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley T, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, Rhee SH, Schlaepfer I, Smolen A, Stallings MC, Young SE, Zeiger JS. Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 596-604. PMID 17226798 DOI: 10.1002/Ajmg.B.30464 |
0.414 |
|
| 2007 |
Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 190: 269-319. PMID 16896961 DOI: 10.1007/S00213-006-0441-0 |
0.622 |
|
| 2006 |
Whiteaker P, Cooper JF, Salminen O, Marks MJ, McClure-Begley TD, Brown RW, Collins AC, Lindstrom JM. Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression. The Journal of Comparative Neurology. 499: 1016-38. PMID 17072836 DOI: 10.1002/Cne.21181 |
0.756 |
|
| 2006 |
Marks MJ, Whiteaker P, Collins AC. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Molecular Pharmacology. 70: 947-59. PMID 16728647 DOI: 10.1124/Mol.106.025338 |
0.438 |
|
| 2006 |
Kelso ML, Wehner JM, Collins AC, Scheff SW, Pauly JR. The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice. Brain Research. 1083: 204-10. PMID 16545784 DOI: 10.1016/J.Brainres.2006.01.127 |
0.487 |
|
| 2006 |
McCallum SE, Collins AC, Paylor R, Marks MJ. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology. 184: 314-27. PMID 16001112 DOI: 10.1007/s00213-005-0076-6 |
0.523 |
|
| 2005 |
Fonck C, Cohen BN, Nashmi R, Whiteaker P, Wagenaar DA, Rodrigues-Pinguet N, Deshpande P, McKinney S, Kwoh S, Munoz J, Labarca C, Collins AC, Marks MJ, Lester HA. Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11396-411. PMID 16339034 DOI: 10.1523/Jneurosci.3597-05.2005 |
0.43 |
|
| 2005 |
Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ. The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay. Neuropharmacology. 48: 696-705. PMID 15814104 DOI: 10.1016/J.Neuropharm.2004.12.011 |
0.481 |
|
| 2005 |
Bowers BJ, McClure-Begley TD, Keller JJ, Paylor R, Collins AC, Wehner JM. Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol. Alcoholism, Clinical and Experimental Research. 29: 295-302. PMID 15770102 DOI: 10.1097/01.Alc.0000156116.40817.A2 |
0.791 |
|
| 2005 |
Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, Marks MJ, Whiteaker P. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion. Molecular Pharmacology. 67: 2007-15. PMID 15749993 DOI: 10.1124/mol.105.011940 |
0.332 |
|
| 2005 |
Butt CM, King NM, Hutton SR, Collins AC, Stitzel JA. Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism. Behavioral Neuroscience. 119: 26-37. PMID 15727510 DOI: 10.1037/0735-7044.119.1.26 |
0.508 |
|
| 2004 |
Marks MJ, Rowell PP, Cao JZ, Grady SR, McCallum SE, Collins AC. Subsets of acetylcholine-stimulated Rb efflux and [I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology. 46: 1141-1157. PMID 32585787 DOI: 10.1016/j.neuropharm.2004.02.009 |
0.408 |
|
| 2004 |
Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science (New York, N.Y.). 306: 1029-32. PMID 15528443 DOI: 10.1126/Science.1099420 |
0.523 |
|
| 2004 |
Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, Grady SR. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology. 65: 1526-35. PMID 15155845 DOI: 10.1124/Mol.65.6.1526 |
0.669 |
|
| 2004 |
Marks MJ, Rowell PP, Cao JZ, Grady SR, McCallum SE, Collins AC. Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology. 46: 1141-57. PMID 15111021 DOI: 10.1016/j.neuropharm.2004.02.009 |
0.505 |
|
| 2004 |
Tritto T, McCallum SE, Waddle SA, Hutton SR, Paylor R, Collins AC, Marks MJ. Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 6: 145-58. PMID 14982698 DOI: 10.1080/14622200310001656966 |
0.562 |
|
| 2004 |
Butt CM, King NM, Stitzel JA, Collins AC. Interaction of the nicotinic cholinergic system with ethanol withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 308: 591-9. PMID 14610221 DOI: 10.1124/Jpet.103.059758 |
0.531 |
|
| 2003 |
Owens JC, Balogh SA, McClure-Begley TD, Butt CM, Labarca C, Lester HA, Picciotto MR, Wehner JM, Collins AC. Alpha 4 beta 2* nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response. Alcoholism, Clinical and Experimental Research. 27: 1867-75. PMID 14691373 DOI: 10.1097/01.Alc.0000102700.72447.0F |
0.814 |
|
| 2003 |
Cui C, Booker TK, Allen RS, Grady SR, Whiteaker P, Marks MJ, Salminen O, Tritto T, Butt CM, Allen WR, Stitzel JA, McIntosh JM, Boulter J, Collins AC, Heinemann SF. The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 11045-53. PMID 14657161 |
0.408 |
|
| 2003 |
Lester HA, Fonck C, Tapper AR, McKinney S, Damaj MI, Balogh S, Owens J, Wehner JM, Collins AC, Labarca C. Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action. Current Opinion in Drug Discovery & Development. 6: 633-9. PMID 14579512 |
0.712 |
|
| 2003 |
Dobelis P, Hutton S, Lu Y, Collins AC. GABAergic systems modulate nicotinic receptor-mediated seizures in mice. The Journal of Pharmacology and Experimental Therapeutics. 306: 1159-66. PMID 12829730 DOI: 10.1124/Jpet.103.053066 |
0.454 |
|
| 2003 |
Butt CM, Hutton SR, Stitzel JA, Balogh SA, Owens JC, Collins AC. A polymorphism in the alpha4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol. Alcoholism, Clinical and Experimental Research. 27: 733-42. PMID 12766617 DOI: 10.1097/01.Alc.0000067973.41153.Bc |
0.73 |
|
| 2003 |
King SL, Marks MJ, Grady SR, Caldarone BJ, Koren AO, Mukhin AG, Collins AC, Picciotto MR. Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 3837-43. PMID 12736354 DOI: 10.1523/Jneurosci.23-09-03837.2003 |
0.659 |
|
| 2003 |
Quik M, Sum JD, Whiteaker P, McCallum SE, Marks MJ, Musachio J, McIntosh JM, Collins AC, Grady SR. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice. Molecular Pharmacology. 63: 1169-79. PMID 12695545 DOI: 10.1124/Mol.63.5.1169 |
0.483 |
|
| 2003 |
Fonck C, Nashmi R, Deshpande P, Damaj MI, Marks MJ, Riedel A, Schwarz J, Collins AC, Labarca C, Lester HA. Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2582-90. PMID 12684443 |
0.374 |
|
| 2003 |
Fonck C, Nashmi R, Deshpande P, Damaj MI, Marks MJ, Riedel A, Schwarz J, Collins AC, Labarca C, Lester HA. Increased Sensitivity to Agonist-Induced Seizures, Straub Tail, and Hippocampal Theta Rhythm in Knock-In Mice Carrying Hypersensitive α4 Nicotinic Receptors The Journal of Neuroscience. 23: 2582-2590. DOI: 10.1523/Jneurosci.23-07-02582.2003 |
0.472 |
|
| 2002 |
Balogh SA, Owens JC, Butt CM, Wehner JM, Collins AC. Animal models as a tool for studying mechanisms of co-abuse of alcohol and tobacco. Alcoholism, Clinical and Experimental Research. 26: 1911-4. PMID 12500117 DOI: 10.1111/J.1530-0277.2002.Tb02500.X |
0.593 |
|
| 2002 |
Butt CM, Hutton SR, Marks MJ, Collins AC. Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. Journal of Neurochemistry. 83: 48-56. PMID 12358728 DOI: 10.1046/J.1471-4159.2002.01135.X |
0.47 |
|
| 2002 |
Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function. Molecular Pharmacology. 62: 334-42. PMID 12130686 DOI: 10.1124/Mol.62.2.334 |
0.527 |
|
| 2002 |
Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. The Journal of Pharmacology and Experimental Therapeutics. 302: 197-204. PMID 12065717 DOI: 10.1124/Jpet.302.1.197 |
0.476 |
|
| 2002 |
Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC. Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice. Journal of Neurochemistry. 81: 1102-15. PMID 12065623 DOI: 10.1046/J.1471-4159.2002.00910.X |
0.668 |
|
| 2002 |
Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC. Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. The Journal of Pharmacology and Experimental Therapeutics. 301: 651-60. PMID 11961070 DOI: 10.1124/jpet.301.2.651 |
0.569 |
|
| 2002 |
Tritto T, Stitzel JA, Marks MJ, Romm E, Collins AC. Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes. Pharmacogenetics. 12: 197-208. PMID 11927835 DOI: 10.1097/00008571-200204000-00004 |
0.527 |
|
| 2002 |
Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaudet AL, Collins AC, Marks MJ. Involvement of the alpha3 subunit in central nicotinic binding populations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2522-9. PMID 11923417 |
0.36 |
|
| 2002 |
Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA. Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. European Journal of Pharmacology. 435: 171-80. PMID 11821023 DOI: 10.1016/S0014-2999(01)01570-9 |
0.529 |
|
| 2002 |
Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaudet AL, Collins AC, Marks MJ. Involvement of the α3 Subunit in Central Nicotinic Binding Populations The Journal of Neuroscience. 22: 2522-2529. DOI: 10.1523/Jneurosci.22-07-02522.2002 |
0.388 |
|
| 2001 |
Adams CE, Stitzel JA, Collins AC, Freedman R. Alpha7-nicotinic receptor expression and the anatomical organization of hippocampal interneurons. Brain Research. 922: 180-90. PMID 11743948 DOI: 10.1016/S0006-8993(01)03115-8 |
0.449 |
|
| 2001 |
Tritto T, Marley RJ, Bastidas D, Stitzel JA, Collins AC. Potential regulation of nicotine and ethanol actions by alpha4-containing nicotinic receptors. Alcohol (Fayetteville, N.Y.). 24: 69-78. PMID 11522425 DOI: 10.1016/S0741-8329(01)00135-5 |
0.556 |
|
| 2001 |
Stevens KE, Bullock AE, Collins AC. Chronic corticosterone treatment alters sensory gating in C3H mice. Pharmacology, Biochemistry, and Behavior. 69: 359-66. PMID 11509192 DOI: 10.1016/S0091-3057(01)00523-8 |
0.499 |
|
| 2001 |
Stitzel JA, Dobelis P, Jimenez M, Collins AC. Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and alpha4 nicotinic receptor subunit cDNA sequence. Pharmacogenetics. 11: 331-9. PMID 11434511 DOI: 10.1097/00008571-200106000-00008 |
0.543 |
|
| 2001 |
Gould TJ, Collins AC, Wehner JM. Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 3: 17-24. PMID 11260807 DOI: 10.1080/14622200125450 |
0.486 |
|
| 2001 |
Vissel B, Royle GA, Christie BR, Schiffer HH, Ghetti A, Tritto T, Perez-Otano I, Radcliffe RA, Seamans J, Sejnowski T, Wehner JM, Collins AC, O'Gorman S, Heinemann SF. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron. 29: 217-27. PMID 11182093 DOI: 10.1016/S0896-6273(01)00192-1 |
0.316 |
|
| 2001 |
Grady SR, Meinerz NM, Cao J, Reynolds AM, Picciotto MR, Changeux JP, McIntosh JM, Marks MJ, Collins AC. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. Journal of Neurochemistry. 76: 258-68. PMID 11145999 DOI: 10.1046/j.1471-4159.2001.00019.x |
0.607 |
|
| 2000 |
Bowers BJ, Collins AC, Wehner JM. Background genotype modulates the effects of γ-PKC on the development of rapid tolerance to ethanol-induced hypothermia. Addiction Biology. 5: 47-58. PMID 20575819 DOI: 10.1080/13556210071261 |
0.359 |
|
| 2000 |
Marks MJ, Stitzel JA, Grady SR, Picciotto MR, Changeux JP, Collins AC. Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotype. Neuropharmacology. 39: 2632-45. PMID 11044733 DOI: 10.1016/S0028-3908(00)00115-5 |
0.644 |
|
| 2000 |
Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. British Journal of Pharmacology. 131: 729-39. PMID 11030722 DOI: 10.1038/Sj.Bjp.0703616 |
0.414 |
|
| 2000 |
Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 351-64. PMID 10989262 DOI: 10.1016/S0893-133X(00)00121-4 |
0.506 |
|
| 2000 |
Bowers BJ, Collins AC, Tritto T, Wehner JM. Mice lacking PKC gamma exhibit decreased anxiety. Behavior Genetics. 30: 111-21. PMID 10979601 DOI: 10.1023/A:1001951104208 |
0.328 |
|
| 2000 |
Stitzel JA, Lu Y, Jimenez M, Tritto T, Collins AC. Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors. Behavioural Brain Research. 113: 57-64. PMID 10942032 DOI: 10.1016/S0166-4328(00)00200-X |
0.495 |
|
| 2000 |
Whiteaker P, McIntosh JM, Luo S, Collins AC, Marks MJ. 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Molecular Pharmacology. 57: 913-25. PMID 10779374 |
0.407 |
|
| 2000 |
Whiteaker P, Marks MJ, Grady SR, Lu Y, Picciotto MR, Changeux JP, Collins AC. Pharmacological and null mutation approaches reveal nicotinic receptor diversity. European Journal of Pharmacology. 393: 123-35. PMID 10771005 DOI: 10.1016/S0014-2999(00)00052-2 |
0.671 |
|
| 2000 |
Sharples CG, Kaiser S, Soliakov L, Marks MJ, Collins AC, Washburn M, Wright E, Spencer JA, Gallagher T, Whiteaker P, Wonnacott S. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 2783-91. PMID 10751429 |
0.385 |
|
| 2000 |
Stitzel JA, Jimenez M, Marks MJ, Tritto T, Collins AC. Potential role of the alpha4 and alpha6 nicotinic receptor subunits in regulating nicotine-induced seizures. The Journal of Pharmacology and Experimental Therapeutics. 293: 67-74. PMID 10734154 |
0.392 |
|
| 2000 |
Sharples CGV, Kaiser S, Soliakov L, Marks MJ, Collins AC, Washburn M, Wright E, Spencer JA, Gallagher T, Whiteaker P, Wonnacott S. UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes The Journal of Neuroscience. 20: 2783-2791. DOI: 10.1523/Jneurosci.20-08-02783.2000 |
0.381 |
|
| 2000 |
Stitzel JA, Leonard SS, Collins AC. Genetic regulation of nicotine-related behaviors and brain nicotinic receptors Handbook of Experimental Pharmacology. 144: 563-585. DOI: 10.1007/978-3-642-57079-7_22 |
0.483 |
|
| 1999 |
Lu Y, Marks MJ, Collins AC. Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. The Journal of Pharmacology and Experimental Therapeutics. 291: 1127-34. PMID 10565833 |
0.351 |
|
| 1999 |
Whiteaker P, Davies AR, Marks MJ, Blagbrough IS, Potter BV, Wolstenholme AJ, Collins AC, Wonnacott S. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. The European Journal of Neuroscience. 11: 2689-96. PMID 10457165 DOI: 10.1046/J.1460-9568.1999.00685.X |
0.454 |
|
| 1999 |
Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacological Reviews. 51: 397-401. PMID 10353988 |
0.365 |
|
| 1999 |
Marks MJ, Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, Picciotto MR, Changeux JP, Collins AC. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. The Journal of Pharmacology and Experimental Therapeutics. 289: 1090-103. PMID 10215692 |
0.595 |
|
| 1999 |
Bowers BJ, Owen EH, Collins AC, Abeliovich A, Tonegawa S, Wehner JM. Decreased Ethanol Sensitivity and Tolerance Development in γ-Protein Kinase C Null Mutant Mice Is Dependent on Genetic Background Alcoholism: Clinical and Experimental Research. 23: 387-397. DOI: 10.1111/J.1530-0277.1999.Tb04127.X |
0.375 |
|
| 1998 |
Lu Y, Grady S, Marks MJ, Picciotto M, Changeux JP, Collins AC. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. The Journal of Pharmacology and Experimental Therapeutics. 287: 648-57. PMID 9808692 |
0.368 |
|
| 1998 |
Booker TK, Smith KW, Dodrill C, Collins AC. Calcium modulation of activation and desensitization of nicotinic receptors from mouse brain. Journal of Neurochemistry. 71: 1490-500. PMID 9751182 DOI: 10.1046/J.1471-4159.1998.71041490.X |
0.427 |
|
| 1998 |
Rogers SW, Gahring LC, Collins AC, Marks M. Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 4825-32. PMID 9634548 |
0.364 |
|
| 1998 |
Marks MJ, Smith KW, Collins AC. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 285: 377-86. PMID 9536034 |
0.312 |
|
| 1998 |
Stitzel JA, Blanchette JM, Collins AC. Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the alpha 5 and alpha 7 nicotinic receptor subunit genes. The Journal of Pharmacology and Experimental Therapeutics. 284: 1104-11. PMID 9495872 |
0.417 |
|
| 1998 |
Rogers SW, Gahring LC, Collins AC, Marks M. Age-Related Changes in Neuronal Nicotinic Acetylcholine Receptor Subunit α4 Expression Are Modified by Long-Term Nicotine Administration The Journal of Neuroscience. 18: 4825-4832. DOI: 10.1523/Jneurosci.18-13-04825.1998 |
0.445 |
|
| 1997 |
Damaj MI, Glassco W, Marks MJ, Slobe B, James JR, May EL, Rosecrans JA, Collins AC, Martin BR. Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog. The Journal of Pharmacology and Experimental Therapeutics. 282: 1425-34. PMID 9316856 |
0.483 |
|
| 1997 |
Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology. 132: 107-24. PMID 9266608 DOI: 10.1007/S002130050327 |
0.322 |
|
| 1997 |
Grady SR, Grun EU, Marks MJ, Collins AC. Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. The Journal of Pharmacology and Experimental Therapeutics. 282: 32-43. PMID 9223537 |
0.341 |
|
| 1997 |
Breese CR, Marks MJ, Logel J, Adams CE, Sullivan B, Collins AC, Leonard S. Effect of smoking history on [3H]nicotine binding in human postmortem brain. The Journal of Pharmacology and Experimental Therapeutics. 282: 7-13. PMID 9223534 |
0.369 |
|
| 1997 |
Bullock AE, Clark AL, Grady SR, Robinson SF, Slobe BS, Marks MJ, Collins AC. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. Journal of Neurochemistry. 68: 2412-23. PMID 9166735 DOI: 10.1046/J.1471-4159.1997.68062412.X |
0.516 |
|
| 1997 |
Booker TK, Collins AC. Long-term ethanol treatment elicits changes in nicotinic receptor binding in only a few brain regions. Alcohol (Fayetteville, N.Y.). 14: 131-40. PMID 9085713 DOI: 10.1016/S0741-8329(96)00116-4 |
0.543 |
|
| 1996 |
Stitzel JA, Farnham DA, Collins AC. Chronic corticosterone treatment elicits dose-dependent changes in mouse brain alpha-bungarotoxin binding. Neuroscience. 72: 791-9. PMID 9157324 DOI: 10.1016/0306-4522(95)00584-6 |
0.436 |
|
| 1996 |
Stitzel JA, Farnham DA, Collins AC. Linkage of strain-specific nicotinic receptor alpha 7 subunit restriction fragment length polymorphisms with levels of alpha-bungarotoxin binding in brain. Brain Research. Molecular Brain Research. 43: 30-40. PMID 9037516 DOI: 10.1016/S0169-328X(96)00149-0 |
0.475 |
|
| 1996 |
Lippiello PM, Bencherif M, Gray JA, Peters S, Grigoryan G, Hodges H, Collins AC. RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization. The Journal of Pharmacology and Experimental Therapeutics. 279: 1422-9. PMID 8968367 |
0.39 |
|
| 1996 |
Collins AC, Wilkins LH, Slobe BS, Cao JZ, Bullock AE. Long-term ethanol and nicotine treatment elicit tolerance to ethanol. Alcoholism, Clinical and Experimental Research. 20: 990-9. PMID 8892517 DOI: 10.1111/J.1530-0277.1996.Tb01936.X |
0.512 |
|
| 1996 |
Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 15: 152-62. PMID 8840351 DOI: 10.1016/0893-133X(95)00178-G |
0.473 |
|
| 1996 |
Marks MJ, Pauly JR, Grun EU, Collins AC. ST/b and DBA/2 mice differ in brain alpha-bungarotoxin binding and alpha 7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis. Brain Research. Molecular Brain Research. 39: 207-22. PMID 8804729 DOI: 10.1016/0169-328X(96)00027-7 |
0.471 |
|
| 1996 |
Pauly JR, Marks MJ, Robinson SF, van de Kamp JL, Collins AC. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. The Journal of Pharmacology and Experimental Therapeutics. 278: 361-9. PMID 8764371 |
0.44 |
|
| 1996 |
Robinson SF, Grun EU, Pauly JR, Collins AC. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice. Pharmacology, Biochemistry, and Behavior. 54: 587-93. PMID 8743633 DOI: 10.1016/0091-3057(95)02281-3 |
0.558 |
|
| 1996 |
Robinson SF, Marks MJ, Collins AC. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology. 124: 332-9. PMID 8739548 DOI: 10.1007/BF02247438 |
0.486 |
|
| 1996 |
Wilson WR, Collins AC. Different levels of [3H]MK-801 binding in long-sleep and short-sleep lines of mice. Alcohol (Fayetteville, N.Y.). 13: 315-20. PMID 8734849 DOI: 10.1016/0741-8329(95)02113-2 |
0.403 |
|
| 1996 |
Christensen SC, Johnson TE, Markel PD, Clark VJ, Fulker DW, Corley RP, Collins AC, Wehner JM. Quantitative trait locus analyses of sleep-times induced by sedative-hypnotics in LSXSS recombinant inbred strains of mice. Alcoholism, Clinical and Experimental Research. 20: 543-50. PMID 8727252 DOI: 10.1111/J.1530-0277.1996.Tb01090.X |
0.31 |
|
| 1996 |
Marks MJ, Robinson SF, Collins AC. Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. The Journal of Pharmacology and Experimental Therapeutics. 277: 1383-96. PMID 8667201 |
0.378 |
|
| 1996 |
Collins AC, Marks MJ. Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Development Research. 38: 231-242. DOI: 10.1002/(SICI)1098-2299(199607/08)38:3/4<231::AID-DDR12>3.0.CO;2-1 |
0.537 |
|
| 1995 |
Grun EU, Pauly JR, Bullock AE, Collins AC. Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity. Pharmacology, Biochemistry, and Behavior. 52: 629-35. PMID 8545485 DOI: 10.1016/0091-3057(95)00157-R |
0.517 |
|
| 1995 |
Cao W, Wehner JM, Collins AC. Chronic intragastric infusion produces tolerance to ethanol in LS and SS mice. Alcohol (Fayetteville, N.Y.). 12: 241-6. PMID 7639958 DOI: 10.1016/0741-8329(94)00101-I |
0.369 |
|
| 1995 |
Marks MJ, Bullock AE, Collins AC. Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. The Journal of Pharmacology and Experimental Therapeutics. 274: 833-41. PMID 7636747 |
0.358 |
|
| 1994 |
Bhat RV, Marks MJ, Collins AC. Effects of chronic nicotine infusion on kinetics of high-affinity nicotine binding. Journal of Neurochemistry. 62: 574-81. PMID 8294920 DOI: 10.1046/J.1471-4159.1994.62020574.X |
0.475 |
|
| 1994 |
Luo Y, Marks MJ, Collins AC. Genotype regulates the development of tolerance to ethanol and cross-tolerance to nicotine. Alcohol (Fayetteville, N.Y.). 11: 167-76. PMID 8204204 DOI: 10.1016/0741-8329(94)90059-0 |
0.471 |
|
| 1994 |
Grady SR, Marks MJ, Collins AC. Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes. Journal of Neurochemistry. 62: 1390-8. PMID 8133269 DOI: 10.1046/J.1471-4159.1994.62041390.X |
0.466 |
|
| 1994 |
van de Kamp JL, Collins AC. Prenatal nicotine alters nicotinic receptor development in the mouse brain. Pharmacology, Biochemistry, and Behavior. 47: 889-900. PMID 8029259 DOI: 10.1016/0091-3057(94)90293-3 |
0.541 |
|
| 1994 |
Collins AC, Luo Y, Selvaag S, Marks MJ. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. The Journal of Pharmacology and Experimental Therapeutics. 271: 125-33. PMID 7965705 |
0.437 |
|
| 1994 |
Marks MJ, Grady SR, Yang JM, Lippiello PM, Collins AC. Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. Journal of Neurochemistry. 63: 2125-35. PMID 7964732 DOI: 10.1046/J.1471-4159.1994.63062125.X |
0.501 |
|
| 1994 |
de Fiebre NC, de Fiebre CM, Booker TK, Nelson S, Collins AC. Bioavailability of ethanol is reduced in several commonly used liquid diets. Alcohol (Fayetteville, N.Y.). 11: 329-35. PMID 7945988 DOI: 10.1016/0741-8329(94)90100-7 |
0.339 |
|
| 1994 |
Robinson SF, Pauly JR, Marks MJ, Collins AC. An analysis of response to nicotine infusion using an automated radiotelemetry system. Psychopharmacology. 115: 115-20. PMID 7862882 DOI: 10.1007/BF02244760 |
0.485 |
|
| 1993 |
Pauly JR, Collins AC. An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation. Neuroendocrinology. 57: 262-71. PMID 8510802 DOI: 10.1159/000126368 |
0.546 |
|
| 1993 |
Marks MJ, Farnham DA, Grady SR, Collins AC. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. The Journal of Pharmacology and Experimental Therapeutics. 264: 542-52. PMID 8437106 |
0.415 |
|
| 1993 |
Cao W, Burkholder T, Wilkins L, Collins AC. A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacology, Biochemistry, and Behavior. 45: 803-9. PMID 8415818 DOI: 10.1016/0091-3057(93)90124-C |
0.458 |
|
| 1993 |
de Fiebre CM, Collins AC. A comparison of the development of tolerance to ethanol and cross-tolerance to nicotine after chronic ethanol treatment in long- and short-sleep mice. The Journal of Pharmacology and Experimental Therapeutics. 266: 1398-406. PMID 8371145 |
0.422 |
|
| 1993 |
Collins AC, Romm E, Selvaag S, Turner S, Marks MJ. A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice. The Journal of Pharmacology and Experimental Therapeutics. 266: 1390-7. PMID 8371144 |
0.392 |
|
| 1993 |
Marks MJ, Grady SR, Collins AC. Downregulation of nicotinic receptor function after chronic nicotine infusion. The Journal of Pharmacology and Experimental Therapeutics. 266: 1268-76. PMID 8371136 |
0.445 |
|
| 1993 |
Pauly JR, Robinson SF, Collins AC. Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice. Brain Research. 620: 195-202. PMID 8369955 DOI: 10.1016/0006-8993(93)90156-H |
0.305 |
|
| 1993 |
Pomerleau OF, Collins AC, Shiffman S, Pomerleau CS. Why some people smoke and others do not: new perspectives. Journal of Consulting and Clinical Psychology. 61: 723-31. PMID 8245270 DOI: 10.1037//0022-006X.61.5.723 |
0.438 |
|
| 1993 |
Cao W, Collins AC. Ethanol effects on 2-deoxyglucose uptake into tissues obtained from LS and SS mice. Alcohol (Fayetteville, N.Y.). 10: 521-7. PMID 8123211 DOI: 10.1016/0741-8329(93)90076-Z |
0.356 |
|
| 1992 |
Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, Collins AC. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 2765-84. PMID 1613557 DOI: 10.1523/Jneurosci.12-07-02765.1992 |
0.548 |
|
| 1992 |
Van de Kamp JL, Collins AC. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors. Pharmacology, Biochemistry, and Behavior. 42: 131-41. PMID 1528936 DOI: 10.1016/0091-3057(92)90457-Q |
0.528 |
|
| 1992 |
Grady S, Marks MJ, Wonnacott S, Collins AC. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. Journal of Neurochemistry. 59: 848-56. PMID 1494911 DOI: 10.1111/J.1471-4159.1992.Tb08322.X |
0.464 |
|
| 1992 |
Pauly JR, Grun EU, Collins AC. Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone. Psychopharmacology. 108: 33-9. PMID 1410144 DOI: 10.1007/BF02245282 |
0.486 |
|
| 1992 |
Grun EA, Pauly JR, Collins AC. Adrenalectomy reverses chronic injection-induced tolerance to nicotine. Psychopharmacology. 109: 299-304. PMID 1365630 DOI: 10.1007/BF02245877 |
0.486 |
|
| 1992 |
de Fiebre CM, Marley RJ, Miner LL, de Fiebre NE, Wehner JM, Collins AC. Classical genetic analyses of responses to sedative-hypnotic drugs in crosses derived from long-sleep and short-sleep mice. Alcoholism, Clinical and Experimental Research. 16: 511-21. PMID 1352660 DOI: 10.1111/J.1530-0277.1992.Tb01409.X |
0.33 |
|
| 1991 |
Collins AC, Marks MJ. Progress towards the development of animal models of smoking-related behaviors. Journal of Addictive Diseases. 10: 109-26. PMID 2065112 DOI: 10.1300/J069v10n01_08 |
0.509 |
|
| 1991 |
de Fiebre CM, Romm E, Collins JT, Draski LJ, Deitrich RA, Collins AC. Responses to cholinergic agonists of rats selectively bred for differential sensitivity to ethanol. Alcoholism, Clinical and Experimental Research. 15: 270-6. PMID 2058804 DOI: 10.1111/J.1530-0277.1991.Tb01868.X |
0.464 |
|
| 1991 |
Bhat RV, Turner SL, Selvaag SR, Marks MJ, Collins AC. Regulation of brain nicotinic receptors by chronic agonist infusion. Journal of Neurochemistry. 56: 1932-9. PMID 2027007 DOI: 10.1111/j.1471-4159.1991.tb03450.x |
0.547 |
|
| 1991 |
Marks MJ, Campbell SM, Romm E, Collins AC. Genotype influences the development of tolerance to nicotine in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 259: 392-402. PMID 1920127 |
0.439 |
|
| 1991 |
Pauly JR, Marks MJ, Gross SD, Collins AC. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. The Journal of Pharmacology and Experimental Therapeutics. 258: 1127-36. PMID 1890617 |
0.453 |
|
| 1990 |
Pauly JR, Grün EU, Collins AC. Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice. Psychopharmacology. 101: 310-6. PMID 2362951 DOI: 10.1007/BF02244047 |
0.535 |
|
| 1990 |
Freund RK, Jungschaffer DA, Collins AC. Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists. Brain Research. 511: 187-91. PMID 2334841 DOI: 10.1016/0006-8993(90)90160-D |
0.514 |
|
| 1990 |
de Fiebre CM, Marks MJ, Collins AC. Ethanol-nicotine interactions in long-sleep and short-sleep mice. Alcohol (Fayetteville, N.Y.). 7: 249-57. PMID 2331320 DOI: 10.1016/0741-8329(90)90014-4 |
0.501 |
|
| 1990 |
Romm E, Lippiello PM, Marks MJ, Collins AC. Purification of L-[3H]nicotine eliminates low affinity binding. Life Sciences. 46: 935-43. PMID 2329919 DOI: 10.1016/0024-3205(90)90095-9 |
0.427 |
|
| 1990 |
Pauly JR, Ullman EA, Collins AC. Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse. Pharmacology, Biochemistry, and Behavior. 35: 171-9. PMID 2315356 DOI: 10.1016/0091-3057(90)90223-5 |
0.471 |
|
| 1990 |
Collins AC, Romm E, Wehner JM. Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors. Brain Research Bulletin. 25: 373-9. PMID 2292034 DOI: 10.1016/0361-9230(90)90222-L |
0.519 |
|
| 1990 |
Fiedler EP, Marks MJ, Collins AC. Postnatal development of two nicotinic cholinergic receptors in seven mouse brain regions. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 8: 533-40. PMID 2281814 DOI: 10.1016/0736-5748(90)90045-4 |
0.474 |
|
| 1990 |
Luntz-Leybman V, Freund RK, Collins AC. 5 alpha-Pregnan-3 alpha-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. European Journal of Pharmacology. 185: 239-42. PMID 2253697 DOI: 10.1016/0014-2999(90)90648-P |
0.468 |
|
| 1990 |
Freund RK, Luntz-Leybman V, Collins AC. Nicotine interferes with GABA-mediated inhibitory processes in mouse hippocampus. Brain Research. 527: 286-91. PMID 2253036 DOI: 10.1016/0006-8993(90)91148-A |
0.482 |
|
| 1990 |
Collins AC. Genetic influences on tobacco use: a review of human and animal studies. The International Journal of the Addictions. 25: 35-55. PMID 2246083 DOI: 10.3109/10826089009067004 |
0.348 |
|
| 1990 |
Collins AC, Campbell SM, Romm E, Marks MJ. A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice. Alcoholism, Clinical and Experimental Research. 14: 605-15. PMID 2221290 DOI: 10.1111/J.1530-0277.1990.Tb01211.X |
0.453 |
|
| 1990 |
Bhat RV, Turner SL, Marks MJ, Collins AC. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion. The Journal of Pharmacology and Experimental Therapeutics. 255: 187-96. PMID 2213555 |
0.451 |
|
| 1990 |
Collins AC, Bhat RV, Pauly JR, Marks MJ. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. Ciba Foundation Symposium. 152: 68-82; discussion 82. PMID 2209260 |
0.432 |
|
| 1990 |
Collins AC. An analysis of the addiction liability of nicotine. Advances in Alcohol & Substance Abuse. 9: 83-101. PMID 2198787 DOI: 10.1300/J251v09n01_06 |
0.435 |
|
| 1990 |
Collins AC. Interactions of ethanol and nicotine at the receptor level. Recent Developments in Alcoholism : An Official Publication of the American Medical Society On Alcoholism, the Research Society On Alcoholism, and the National Council On Alcoholism. 8: 221-31. PMID 2185519 |
0.412 |
|
| 1990 |
Collins AC, Grun EU, Pauly JR. Potential role of corticosterone in regulating tolerance to nicotine European Journal of Pharmacology. 183: 2355-2356. DOI: 10.1016/0014-2999(90)93917-F |
0.335 |
|
| 1990 |
Van De Kamp JL, Wehner JM, Collins AC. Effect of chronic nicotine infusion on spatial learning ability European Journal of Pharmacology. 183: 932-933. DOI: 10.1016/0014-2999(90)92770-J |
0.366 |
|
| 1989 |
Collins AC, Marks MJ, Pauly JR. Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice. Journal of Substance Abuse. 1: 273-86. PMID 7580219 DOI: 10.1016/S0899-3289(18)30004-X |
0.524 |
|
| 1989 |
Miner LL, Collins AC. Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacology, Biochemistry, and Behavior. 33: 469-75. PMID 2813485 DOI: 10.1016/0091-3057(89)90532-7 |
0.475 |
|
| 1989 |
de Fiebre CM, Collins AC. Behavioral desensitization to nicotine is enhanced differentially by ethanol in long-sleep and short-sleep mice. Alcohol (Fayetteville, N.Y.). 6: 45-51. PMID 2719818 DOI: 10.1016/0741-8329(89)90072-4 |
0.488 |
|
| 1989 |
Pauly JR, Stitzel JA, Marks MJ, Collins AC. An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Research Bulletin. 22: 453-9. PMID 2706548 DOI: 10.1016/0361-9230(89)90072-5 |
0.479 |
|
| 1989 |
Collins AC, Marks MJ. Chronic nicotine exposure and brain nicotinic receptors--influence of genetic factors. Progress in Brain Research. 79: 137-46. PMID 2587740 |
0.373 |
|
| 1989 |
Marks MJ, Romm E, Campbell SM, Collins AC. Variation of nicotinic binding sites among inbred strains. Pharmacology, Biochemistry, and Behavior. 33: 679-89. PMID 2587609 DOI: 10.1016/0091-3057(89)90407-3 |
0.458 |
|
| 1989 |
Marks MJ, Stitzel JA, Collins AC. Genetic influences on nicotine responses. Pharmacology, Biochemistry, and Behavior. 33: 667-78. PMID 2587608 DOI: 10.1016/0091-3057(89)90406-1 |
0.421 |
|
| 1989 |
Bigelow SW, Collins AC, Nebert DW. Selective mouse breeding for short ethanol sleep time has led to high levels of hepatic aromatic hydrocarbon (Ah) receptor. Biochemical Pharmacology. 38: 3565-72. PMID 2554926 DOI: 10.1016/0006-2952(89)90129-9 |
0.346 |
|
| 1989 |
Collins AC, Marks MJ. Chapter 13 Chronic nicotine exposure and brain nicotinic receptors—influence of genetic factors Progress in Brain Research. 79: 137-146. DOI: 10.1016/S0079-6123(08)62473-5 |
0.505 |
|
| 1988 |
Miner LL, Collins AC. Effect of nicotine pretreatment on nicotine-induced seizures. Pharmacology, Biochemistry, and Behavior. 29: 375-80. PMID 3362931 DOI: 10.1016/0091-3057(88)90171-2 |
0.506 |
|
| 1988 |
Collins AC, Burch JB, de Fiebre CM, Marks MJ. Tolerance to and cross tolerance between ethanol and nicotine. Pharmacology, Biochemistry, and Behavior. 29: 365-73. PMID 3362930 DOI: 10.1016/0091-3057(88)90170-0 |
0.52 |
|
| 1988 |
de Fiebre CM, Collins AC. Decreased sensitivity to nicotine-induced seizures as a consequence of nicotine pretreatment in long-sleep and short-sleep mice. Alcohol (Fayetteville, N.Y.). 5: 55-61. PMID 3355671 DOI: 10.1016/0741-8329(88)90044-4 |
0.49 |
|
| 1988 |
Stitzel JA, Campbell SM, Collins AC, Marks MJ. Sulfhydryl modification of two nicotinic binding sites in mouse brain. Journal of Neurochemistry. 50: 920-8. PMID 3339366 DOI: 10.1111/J.1471-4159.1988.Tb03000.X |
0.481 |
|
| 1988 |
Pauly JR, Ullman EA, Collins AC. Adrenocortical hormone regulation of nicotine sensitivity in mice. Physiology & Behavior. 44: 109-16. PMID 3237805 DOI: 10.1016/0031-9384(88)90353-8 |
0.535 |
|
| 1988 |
Freund RK, Martin BJ, Jungschaffer DA, Ullman EA, Collins AC. Genetic differences in plasma corticosterone levels in response to nicotine injection. Pharmacology, Biochemistry, and Behavior. 30: 1059-64. PMID 3227029 DOI: 10.1016/0091-3057(88)90139-6 |
0.419 |
|
| 1988 |
Collins AC, Miner LL, Marks MJ. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacology, Biochemistry, and Behavior. 30: 269-78. PMID 3174752 DOI: 10.1016/0091-3057(88)90455-8 |
0.517 |
|
| 1988 |
Collins AC, Romm E, Wehner JM. Nicotine tolerance: an analysis of the time course of its development and loss in the rat. Psychopharmacology. 96: 7-14. PMID 3147478 DOI: 10.1007/Bf02431526 |
0.507 |
|
| 1988 |
Burch JB, de Fiebre CM, Marks MJ, Collins AC. Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents. Psychopharmacology. 95: 452-8. PMID 3145516 DOI: 10.1007/Bf00172954 |
0.522 |
|
| 1988 |
Miner LL, Collins AC. The effect of chronic nicotine treatment on nicotine-induced seizures. Psychopharmacology. 95: 52-5. PMID 3133700 DOI: 10.1007/BF00212766 |
0.515 |
|
| 1988 |
Freund RK, Jungschaffer DA, Collins AC, Wehner JM. Evidence for modulation of GABAergic neurotransmission by nicotine. Brain Research. 453: 215-20. PMID 2841012 DOI: 10.1016/0006-8993(88)90160-6 |
0.434 |
|
| 1987 |
Marks MJ, Romm E, Collins AC. Genetic influences on tolerance development with chronic oxotremorine infusion. Pharmacology, Biochemistry, and Behavior. 27: 723-32. PMID 3659096 DOI: 10.1016/0091-3057(87)90200-0 |
0.418 |
|
| 1987 |
Fiedler EP, Marks MJ, Collins AC. Postnatal development of cholinergic enzymes and receptors in mouse brain. Journal of Neurochemistry. 49: 983-90. PMID 3612135 DOI: 10.1111/J.1471-4159.1987.Tb00990.X |
0.503 |
|
| 1987 |
Smolen A, Smolen TN, Han PC, Collins AC. Sex differences in the recovery of brain acetylcholinesterase activity following a single exposure to DFP. Pharmacology, Biochemistry, and Behavior. 26: 813-20. PMID 3602038 DOI: 10.1016/0091-3057(87)90615-0 |
0.415 |
|
| 1987 |
Romm E, Collins AC. Body temperature influences on ethanol elimination rate. Alcohol (Fayetteville, N.Y.). 4: 189-98. PMID 3593533 DOI: 10.1016/0741-8329(87)90042-5 |
0.33 |
|
| 1987 |
Collins AC, Smolen TN, Smolen A, Medhurst LJ. Cross-tolerance between muscarinic agonists: role of muscarinic receptors. Pharmacology, Biochemistry, and Behavior. 26: 173-82. PMID 3562489 DOI: 10.1016/0091-3057(87)90551-X |
0.403 |
|
| 1987 |
De Fiebre CM, Medhurst LJ, Collins AC. Nicotine response and nicotinic receptors in long-sleep and short-sleep mice. Alcohol (Fayetteville, N.Y.). 4: 493-501. PMID 3435639 DOI: 10.1016/0741-8329(87)90092-9 |
0.536 |
|
| 1987 |
Marks MJ, Romm E, Collins AC. Mouse brain ATPase activities after chronic nicotine infusion. Biochemical Pharmacology. 36: 3318-20. PMID 2822051 DOI: 10.1016/0006-2952(87)90655-1 |
0.441 |
|
| 1987 |
Marks MJ, Stitzel JA, Collins AC. Influence of kinetics of nicotine administration on tolerance development and receptor levels. Pharmacology, Biochemistry, and Behavior. 27: 505-12. PMID 2821553 DOI: 10.1016/0091-3057(87)90355-8 |
0.467 |
|
| 1986 |
Smolen TN, Smolen A, Collins AC. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP. Pharmacology, Biochemistry, and Behavior. 25: 1293-301. PMID 3809233 DOI: 10.1016/0091-3057(86)90125-5 |
0.343 |
|
| 1986 |
Miner LL, Marks MJ, Collins AC. Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 239: 853-60. PMID 3795045 |
0.36 |
|
| 1986 |
Marks MJ, Stitzel JA, Collins AC. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. The Journal of Pharmacology and Experimental Therapeutics. 239: 358-64. PMID 3772799 |
0.411 |
|
| 1986 |
Collins AC, Evans CB, Miner LL, Marks MJ. Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors. Pharmacology, Biochemistry, and Behavior. 24: 1767-73. PMID 3737641 DOI: 10.1016/0091-3057(86)90518-6 |
0.532 |
|
| 1986 |
Smolen A, Smolen TN, Oh EI, Collins AC. A strain comparison of physiological and locomotor responses of mice to diisopropylfluorosphosphate. Pharmacology, Biochemistry, and Behavior. 24: 1077-82. PMID 3714764 DOI: 10.1016/0091-3057(86)90458-2 |
0.398 |
|
| 1986 |
Marks MJ, Romm E, Gaffney DK, Collins AC. Nicotine-induced tolerance and receptor changes in four mouse strains. The Journal of Pharmacology and Experimental Therapeutics. 237: 809-19. PMID 3712280 |
0.441 |
|
| 1986 |
Marks MJ, Miner LL, Cole-Harding S, Burch JB, Collins AC. A genetic analysis of nicotine effects on open field activity. Pharmacology, Biochemistry, and Behavior. 24: 743-9. PMID 3703908 DOI: 10.1016/0091-3057(86)90584-8 |
0.419 |
|
| 1986 |
Gilliam DM, Collins AC. Quantification of physiological and behavioral measures of alcohol withdrawal in long-sleep and short-sleep mice. Alcoholism, Clinical and Experimental Research. 10: 672-8. PMID 3544922 DOI: 10.1111/J.1530-0277.1986.Tb05166.X |
0.333 |
|
| 1986 |
Marks MJ, Stitzel JA, Romm E, Wehner JM, Collins AC. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Molecular Pharmacology. 30: 427-36. PMID 3534542 |
0.373 |
|
| 1986 |
Smolen A, Marks MJ, Smolen TN, Collins AC. Dose and route of administration alter the relative elimination of ethanol by long-sleep and short-sleep mice. Alcoholism, Clinical and Experimental Research. 10: 198-204. PMID 3521378 DOI: 10.1111/J.1530-0277.1986.Tb05071.X |
0.345 |
|
| 1985 |
Marks MJ, Stitzel JA, Collins AC. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. The Journal of Pharmacology and Experimental Therapeutics. 235: 619-28. PMID 4078726 |
0.423 |
|
| 1985 |
Marks MJ, Romm E, Bealer SM, Collins AC. A test battery for measuring nicotine effects in mice. Pharmacology, Biochemistry, and Behavior. 23: 325-30. PMID 4059317 DOI: 10.1016/0091-3057(85)90577-5 |
0.36 |
|
| 1985 |
Miner LL, Marks MJ, Collins AC. Relationship between nicotine-induced seizures and hippocampal nicotinic receptors. Life Sciences. 37: 75-83. PMID 4010471 DOI: 10.1016/0024-3205(85)90628-9 |
0.52 |
|
| 1985 |
Smolen A, Smolen TN, Wehner JM, Collins AC. Genetically determined differences in acute responses to diisopropylfluorophosphate. Pharmacology, Biochemistry, and Behavior. 22: 623-30. PMID 3991771 DOI: 10.1016/0091-3057(85)90285-0 |
0.359 |
|
| 1985 |
Marks MJ, Collins AC. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine. Pharmacology, Biochemistry, and Behavior. 22: 283-91. PMID 3983219 DOI: 10.1016/0091-3057(85)90392-2 |
0.548 |
|
| 1985 |
George FR, Ritz MC, Collins AC. Indomethacin antagonism of ethanol-induced sleep time: sex and genotypic factors. Psychopharmacology. 85: 151-3. PMID 3925481 DOI: 10.1007/BF00428405 |
0.367 |
|
| 1985 |
Collins AC, Gilliam DM, Miner LL. Indomethacin pretreatment blocks the effects of high concentrations of ethanol. Alcoholism, Clinical and Experimental Research. 9: 371-6. PMID 3901810 DOI: 10.1111/J.1530-0277.1985.Tb05562.X |
0.356 |
|
| 1985 |
George FR, Collins AC. Ethanol's behavioral effects may be partly due to increases in brain prostaglandin production. Alcoholism, Clinical and Experimental Research. 9: 143-6. PMID 3890595 DOI: 10.1111/J.1530-0277.1985.Tb05539.X |
0.334 |
|
| 1984 |
Marks MJ, O'Connor MF, Artman LD, Burch JB, Collins AC. Chronic scopolamine treatment and brain cholinergic function. Pharmacology, Biochemistry, and Behavior. 20: 771-7. PMID 6739517 DOI: 10.1016/0091-3057(84)90198-9 |
0.423 |
|
| 1984 |
Smolen TN, Collins AC. Behavioral effects of ethanol and salsolinol in mice selectively bred for acute sensitivity to ethanol. Pharmacology, Biochemistry, and Behavior. 20: 281-7. PMID 6718455 DOI: 10.1016/0091-3057(84)90255-7 |
0.371 |
|
| 1984 |
Smolen TN, Howerton TC, Collins AC. Effects of ethanol and salsolinol on catecholamine function in LS and SS mice. Pharmacology, Biochemistry, and Behavior. 20: 125-31. PMID 6694991 DOI: 10.1016/0091-3057(84)90112-6 |
0.377 |
|
| 1984 |
Howerton TC, Collins AC. Ethanol-induced inhibition of norepinephrine release from brain slices obtained from LS and SS mice. Alcohol (Fayetteville, N.Y.). 1: 47-53. PMID 6598955 DOI: 10.1016/0741-8329(84)90036-3 |
0.355 |
|
| 1984 |
Howerton TC, Collins AC. Ethanol-induced inhibition of GABA release from LS and SS mouse brain slices. Alcohol (Fayetteville, N.Y.). 1: 471-7. PMID 6598752 DOI: 10.1016/0741-8329(84)90024-7 |
0.389 |
|
| 1984 |
Marks MJ, Miner L, Burch JB, Fulker DW, Collins AC. A diallel analysis of nicotine-induced hypothermia. Pharmacology, Biochemistry, and Behavior. 21: 953-9. PMID 6522421 DOI: 10.1016/S0091-3057(84)80079-9 |
0.472 |
|
| 1984 |
Miner LL, Marks MJ, Collins AC. Classical genetic analysis of nicotine-induced seizures and nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 231: 545-54. PMID 6502513 |
0.434 |
|
| 1984 |
Collins AC, Smolen A, Wayman AL, Marks MJ. Ethanol and temperature effects on five membrane bound enzymes. Alcohol (Fayetteville, N.Y.). 1: 237-46. PMID 6152601 DOI: 10.1016/0741-8329(84)90104-6 |
0.311 |
|
| 1984 |
Howerton TC, Burch JB, O'Connor MF, Miner LL, Collins AC. A genetic analysis of ethanol, pentobarbital, and methyprylon sleep-time response. Alcoholism, Clinical and Experimental Research. 8: 546-50. PMID 6151363 DOI: 10.1111/J.1530-0277.1984.Tb05727.X |
0.316 |
|
| 1984 |
Marks MJ, Smolen A, Collins AC. Brain NaK-ATPases in mice differentially sensitive to alcohols. Alcoholism, Clinical and Experimental Research. 8: 390-6. PMID 6091491 DOI: 10.1111/J.1530-0277.1984.Tb05685.X |
0.382 |
|
| 1983 |
Marks MJ, Burch JB, Collins AC. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 226: 817-25. PMID 6887012 |
0.4 |
|
| 1983 |
Marks MJ, Burch JB, Collins AC. Genetics of nicotine response in four inbred strains of mice. The Journal of Pharmacology and Experimental Therapeutics. 226: 291-302. PMID 6864548 |
0.429 |
|
| 1983 |
Marks MJ, Artman LD, Collins AC. Quantitation of tolerance development after chronic oxotremorine treatment. Pharmacology, Biochemistry, and Behavior. 19: 103-13. PMID 6622504 DOI: 10.1016/0091-3057(83)90318-0 |
0.344 |
|
| 1983 |
Howerton TC, O'Connor MF, Collins AC. Differential effects of long-chain alcohols in long- and short-sleep mice. Psychopharmacology. 79: 313-7. PMID 6407044 DOI: 10.1007/BF00433408 |
0.354 |
|
| 1983 |
Gilliam DM, Collins AC. Differential effects of ethanol concentration on blood pH, PCO2 and PO2 in LS and SS mice. Physiology & Behavior. 30: 295-300. PMID 6405413 DOI: 10.1016/0031-9384(83)90022-7 |
0.356 |
|
| 1983 |
Gilliam DM, Collins AC. Concentration-dependent effects of ethanol in long-sleep and short-sleep mice. Alcoholism, Clinical and Experimental Research. 7: 337-42. PMID 6353987 DOI: 10.1111/J.1530-0277.1983.Tb05474.X |
0.351 |
|
| 1983 |
Gilliam DM, Bloedow DC, Collins AC. Nonlinear pharmacokinetics of ethanol elimination in long sleep and short sleep mice. Alcoholism, Clinical and Experimental Research. 7: 95-9. PMID 6342455 DOI: 10.1111/J.1530-0277.1983.Tb05420.X |
0.342 |
|
| 1983 |
Gilliam DM, Collins AC. Circadian and genetic influences on tissue sensitivity and sleep time to ethanol in LS and SS mice. Pharmacology, Biochemistry, and Behavior. 18: 803-8. PMID 6304785 DOI: 10.1016/0091-3057(83)90026-6 |
0.315 |
|
| 1983 |
George FR, Howerton TC, Elmer GI, Collins AC. Antagonism of alcohol hypnosis by blockade of prostaglandin synthesis and activity: genotype and time course effects. Pharmacology, Biochemistry, and Behavior. 19: 131-6. PMID 6137834 DOI: 10.1016/0091-3057(83)90321-0 |
0.36 |
|
| 1982 |
Marks MJ, Collins AC. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Molecular Pharmacology. 22: 554-64. PMID 7155123 |
0.421 |
|
| 1982 |
O'Connor MF, Howerton TC, Collins AC. Effects of pentobarbital in mice selected for differential sensitivity to ethanol. Pharmacology, Biochemistry, and Behavior. 17: 245-8. PMID 7134236 DOI: 10.1016/0091-3057(82)90077-6 |
0.364 |
|
| 1982 |
Gilliam DM, Collins AC. Acute ethanol effects on blood pH, PCO2, and PO2 in LS and SS mice. Physiology & Behavior. 28: 879-83. PMID 6808530 DOI: 10.1016/0031-9384(82)90208-6 |
0.361 |
|
| 1982 |
Gilliam DM, Collins AC. Circadian and genetic effects on ethanol elimination in LS and SS mice. Alcoholism, Clinical and Experimental Research. 6: 344-9. PMID 6751129 DOI: 10.1111/J.1530-0277.1982.Tb04989.X |
0.36 |
|
| 1981 |
Fish BS, Rank SA, Wilson JR, Collins AC. Viability and sensorimotor development of mice exposed to prenatal short-term ethanol. Pharmacology, Biochemistry, and Behavior. 14: 57-65. PMID 7465609 DOI: 10.1016/0091-3057(81)90103-9 |
0.337 |
|
| 1981 |
Marks MJ, Patinkin DM, Artman LD, Burch JB, Collins AC. Genetic influences on cholinergic drug response. Pharmacology, Biochemistry, and Behavior. 15: 271-9. PMID 7312897 DOI: 10.1016/0091-3057(81)90187-8 |
0.404 |
|
| 1981 |
Marks MJ, Artman LD, Patinkin DM, Collins AC. Cholinergic adaptations to chronic oxotremorine infusion. The Journal of Pharmacology and Experimental Therapeutics. 218: 337-43. PMID 7252834 |
0.302 |
|
| 1981 |
George FR, Jackson SJ, Collins AC. Prostaglandin synthetase inhibitors antagonize hypothermia induced by sedative hypnotics. Psychopharmacology. 74: 241-4. PMID 6791232 DOI: 10.1007/BF00427102 |
0.346 |
|
| 1980 |
Hatchell PC, Collins AC. The influence of genotype and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology. 71: 45-9. PMID 6779324 DOI: 10.1007/BF00433251 |
0.442 |
|
| 1979 |
George FR, Collins AC. Prostaglandin synthetase inhibitors antagonize the depressant effects of ethanol. Pharmacology, Biochemistry, and Behavior. 10: 865-9. PMID 113788 DOI: 10.1016/0091-3057(79)90059-5 |
0.344 |
|
| 1978 |
Sanders B, Sharpless SK, Collins AC, McClearn GE, Flanagan C. Activating and anesthetic effects of general depressants. Psychopharmacology. 56: 185-9. PMID 417369 DOI: 10.1007/Bf00431847 |
0.333 |
|
| 1977 |
Petersen DR, Panter SS, Collins AC. Ethanol and acetaldehyde metabolism in the pregnant mouse. Drug and Alcohol Dependence. 2: 409-20. PMID 913241 DOI: 10.1016/0376-8716(77)90042-4 |
0.307 |
|
| 1977 |
Sanders B, Collins AC, Petersen DR, Fish BS. Effects of three monoamine oxidase inhibitors on ethanol preference in mice. Pharmacology, Biochemistry, and Behavior. 6: 319-24. PMID 857255 DOI: 10.1016/0091-3057(77)90031-4 |
0.344 |
|
| 1977 |
Hatchell PC, Collins AC. Influences of genotype and sex on behavioral tolerance to nicotine in mice. Pharmacology, Biochemistry, and Behavior. 6: 25-30. PMID 850690 DOI: 10.1016/0091-3057(77)90156-3 |
0.36 |
|
| 1977 |
Lebsack ME, Petersen DR, Collins AC, Anderson AD. Preferential inhibition of the low Km aldehyde dehydrogenase activity by pargyline. Biochemical Pharmacology. 26: 1151-4. PMID 560851 DOI: 10.1016/0006-2952(77)90060-0 |
0.343 |
|
| 1976 |
Greer CA, Alpern HP, Collins AC. Increased CNS sensitivity to flurothyl as a measure of physical dependence in mice following morphine, phenobarbital, and ethanol treatment. Life Sciences. 18: 1375-82. PMID 945859 DOI: 10.1016/0024-3205(76)90353-2 |
0.346 |
|
| 1976 |
Sanders B, Collins AC, Wesley VH. Reduction of alcohol selection by pargyline in mice. Psychopharmacologia. 46: 159-62. PMID 133369 DOI: 10.1007/Bf00421385 |
0.337 |
|
| 1975 |
Alpern HP, Greer CA, Stripling JS, Collins AC, Olson RK. Methaqualone: tolerance and physical dependence in mice. Psychopharmacologia. 44: 303-5. PMID 1239784 DOI: 10.1007/Bf00428912 |
0.309 |
|
| Show low-probability matches. |